NCT03238820

Brief Summary

Patients with gastric gastrointestinal stromal tumors will receive robotic resection.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2014

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 5, 2016

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 27, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 3, 2017

Completed
Last Updated

August 3, 2017

Status Verified

July 1, 2017

Enrollment Period

2.6 years

First QC Date

July 27, 2017

Last Update Submit

July 31, 2017

Conditions

Keywords

Gastrointestinal stromal tumorsRobotmanual suture

Outcome Measures

Primary Outcomes (1)

  • Complications

    Intraoperative and postoperative complications

    1 month

Secondary Outcomes (7)

  • Blood loss

    1 day

  • Operative time

    1 day

  • Resection style

    1 day

  • Postoperative length of stay

    1 month

  • Inflammation level

    1 month

  • +2 more secondary outcomes

Study Arms (1)

The robot group

EXPERIMENTAL

Patients undergo robotic gastric gastrointestinal stromal tumors resection.

Procedure: Robotic gastric gastrointestinal stromal tumors resection

Interventions

Robotic gastric gastrointestinal stromal tumors resection

The robot group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Requirements of informed consent and assent of participant, parent or legal guardian as applicable.
  • Patients with gastric gastrointestinal stromal tumors scheduled for robotic resection and between the age of 18 and 80 years old without considering sex.
  • American Society of Anesthesiologists (ASA) physical status I-III.
  • Participants can follow the visit plan.

You may not qualify if:

  • Patients certified by a doctor that doesn't fit to participate in this study.
  • Patients with ischemic heart disease, cerebrovascular disease and peripheral vascular disease, or their cardiac function \> II (NYHA) patients, patients received coronary artery bypass grafting (CABG) recently, and patients with severe hypertension (systolic pressure≥180mmHg or diastolic pressure≥110mmHg).
  • Patients with gastrointestinal stromal tumor with distant metastasis.
  • Patients with severe infection, respiratory dysfunction, coagulation disorders, severe liver and renal dysfunction (Child - Pugh≥ 10; creatinine clearance \< 25 ml/min).
  • Patients with gastrointestinal operations and complicated abdominal operations.
  • Patients with severe malnutrition (albumin≤30g/L, weight loss in half a year\>10%, Subjective Global Assessment (SGA) classification C, body mass index \<18, Hb\<70g/L).
  • Pregnancy and lactation women, or have a pregnancy plan within a month after the test of the subjects (also including male participants).
  • Patients participated other subjects 3 months before this subject.
  • Sponsors or researchers directly involved in the testing or their family members.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jinling Hospital, Medical School of Nanjing University

Nanjing, Jiangsu, 210002, China

Location

MeSH Terms

Conditions

Gastrointestinal Stromal Tumors

Condition Hierarchy (Ancestors)

Neoplasms, Connective TissueNeoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsDigestive System DiseasesGastrointestinal Diseases

Study Officials

  • Zhi-Wei JIANG, Ph.D.

    Jinling Hospital, Medical School of Nanjing University

    PRINCIPAL INVESTIGATOR
  • Jian ZHAO, Ph.D.

    Jinling Hospital, Medical School of Nanjing University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: This is a single group, open study.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Vice director of Research Institute of General Surgery

Study Record Dates

First Submitted

July 27, 2017

First Posted

August 3, 2017

Study Start

January 10, 2014

Primary Completion

August 5, 2016

Study Completion

June 1, 2017

Last Updated

August 3, 2017

Record last verified: 2017-07

Locations